Evidence map›Paper›PMID 38926287›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

High-Throughput Protein Expression Screening of Cell-Surface Protein Ectodomains.

Anita Ghosh, Chang Yang, Kenneth Lloyd, Rob Meijers

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anita GhoshInstitute for Protein Innovation (IPI), Boston, MA, USA.
Chang YangInstitute for Protein Innovation (IPI), Boston, MA, USA.
Kenneth LloydInstitute for Protein Innovation (IPI), Boston, MA, USA.
Rob MeijersInstitute for Protein Innovation (IPI), Boston, MA, USA. rob.meijers@proteininnovation.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-surface receptors can be difficult to express and purify for structural and biochemical studies due to low expression levels, misfolding, aggregation, and instability. Cell-surface receptor ectodomains are more amenable to large-scale production, but this requires designing and testing various truncation constructs. However, since each protein is unique, testing these constructs individually for many targets is a time-consuming process. In this context, we present a high-throughput ELISA fluorescence approach that allows the rapid assessment of numerous recombinant constructs simultaneously. Cell-surface ectodomains are expressed in small scale, enzymatically biotinylated, and detected using a C-terminal His-tag. As an example, we tested the expression of truncation constructs for the neurexin, neuroligin, and latrophilin families and show that the small-scale ELISA allowed us to prioritize well-expressing construct for large-scale production. By employing this method, one can efficiently detect clones with low expression levels, streamlining the process and saving valuable time in identifying optimal candidates for further study.

Indexed as

Enzyme-Linked Immunosorbent AssayHigh-Throughput Screening AssaysGene ExpressionHEK293 CellsHumansMembrane ProteinsProtein DomainsRecombinant ProteinsMembrane ProteinsRecombinant ProteinsBiotin Ligase (BirA) enzymeCell-surface receptorsELISAEnzymatic biotinylationFluorescenceHigh-throughputLow expressionMammalian proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.